Juuso Väistö1,2, Eero A Haapala1,3, Anna Viitasalo1, Theresia M Schnurr4, Tuomas O Kilpeläinen4, Panu Karjalainen1, Kate Westgate5, Hanna-Maaria Lakka1, David E Laaksonen6, Ulf Ekelund5,7, Søren Brage5, Timo A Lakka1,8,9. 1. Institute of Biomedicine, Physiology, University of Eastern Finland, Kuopio, Finland. 2. Institute of Dentistry, School of Medicine, University of Eastern Finland, Kuopio, Finland. 3. Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland. 4. Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 5. MRC Epidemiology Unit, Institute of Metabolic Science, School of Clinical Medicine, University of Cambridge, Cambridge, UK. 6. Institute of Clinical Medicine, Internal Medicine, Kuopio University Hospital, Kuopio, Finland. 7. Department of Sport Medicine, Norwegian School of Sport Sciences, Oslo, Norway. 8. Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland. 9. Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
Abstract
BACKGROUND: There are few prospective studies on the associations of changes in objectively measured vigorous physical activity (VPA∆ ), moderate-to-vigorous physical activity (MVPA∆ ), light physical activity (LPA∆ ), and sedentary time (ST∆ ) with changes in cardiometabolic risk factors (∆ ) in children. We therefore investigated these relationships among children. METHODS: The participants were a population sample of 258 children aged 6-8 years followed for 2 years. We assessed PA and ST by a combined heart rate and movement sensor; computed continuous age- and sex-adjusted z-scores for waist circumference, blood pressure, and fasting insulin, glucose, triglycerides, and high-density lipoprotein (HDL) cholesterol; and constructed a cardiometabolic risk score (CRS) of these risk factors. Data were analyzed using linear regression models adjusted for age, sex, the explanatory and outcome variables at baseline, and puberty. RESULTS: VPA∆ associated inversely with CRS∆ (β = -0.209, P = 0.001), body fat percentage (BF%)∆ (β = -0.244, P = 0.001), insulin∆ (β = -0.220, P = 0.001), and triglycerides∆ (β = -0.164, P = 0.012) and directly with HDL cholesterol∆ (β = 0.159, P = 0.023). MVPA∆ associated inversely with CRS∆ (β = -0.178, P = 0.012), BF%∆ (β = -0.298, P = <0.001), and insulin∆ (β = -0.213, P = 0.006) and directly with HDL cholesterol∆ (β = 0.184, P = 0.022). LPA∆ only associated negatively with CRS∆ (β = -0.163, P = 0.032). ST∆ associated directly with CRS∆ (β = 0.218, P = 0.003), BF%∆ (β = 0.212, P = 0.016), and insulin∆ (β = 0.159, P = 0.049). CONCLUSIONS: Increased VPA and MVPA and decreased ST were associated with reduced overall cardiometabolic risk and major individual risk factors. Change in LPA had weaker associations with changes in these cardiometabolic risk factors. Our findings suggest that increasing at least moderate-intensity PA and decreasing ST decrease cardiometabolic risk in children.
BACKGROUND: There are few prospective studies on the associations of changes in objectively measured vigorous physical activity (VPA∆ ), moderate-to-vigorous physical activity (MVPA∆ ), light physical activity (LPA∆ ), and sedentary time (ST∆ ) with changes in cardiometabolic risk factors (∆ ) in children. We therefore investigated these relationships among children. METHODS: The participants were a population sample of 258 children aged 6-8 years followed for 2 years. We assessed PA and ST by a combined heart rate and movement sensor; computed continuous age- and sex-adjusted z-scores for waist circumference, blood pressure, and fasting insulin, glucose, triglycerides, and high-density lipoprotein (HDL) cholesterol; and constructed a cardiometabolic risk score (CRS) of these risk factors. Data were analyzed using linear regression models adjusted for age, sex, the explanatory and outcome variables at baseline, and puberty. RESULTS: VPA∆ associated inversely with CRS∆ (β = -0.209, P = 0.001), body fat percentage (BF%)∆ (β = -0.244, P = 0.001), insulin∆ (β = -0.220, P = 0.001), and triglycerides∆ (β = -0.164, P = 0.012) and directly with HDL cholesterol∆ (β = 0.159, P = 0.023). MVPA∆ associated inversely with CRS∆ (β = -0.178, P = 0.012), BF%∆ (β = -0.298, P = <0.001), and insulin∆ (β = -0.213, P = 0.006) and directly with HDL cholesterol∆ (β = 0.184, P = 0.022). LPA∆ only associated negatively with CRS∆ (β = -0.163, P = 0.032). ST∆ associated directly with CRS∆ (β = 0.218, P = 0.003), BF%∆ (β = 0.212, P = 0.016), and insulin∆ (β = 0.159, P = 0.049). CONCLUSIONS: Increased VPA and MVPA and decreased ST were associated with reduced overall cardiometabolic risk and major individual risk factors. Change in LPA had weaker associations with changes in these cardiometabolic risk factors. Our findings suggest that increasing at least moderate-intensity PA and decreasing ST decrease cardiometabolic risk in children.
Authors: Søren Brage; Niels Wedderkopp; Ulf Ekelund; Paul W Franks; Nicholas J Wareham; Lars Bo Andersen; Karsten Froberg Journal: Diabetes Care Date: 2004-09 Impact factor: 19.112
Authors: Luis B Sardinha; Lars Bo Andersen; Sigmund A Anderssen; Ana L Quitério; Rui Ornelas; Karsten Froberg; Chris J Riddoch; Ulf Ekelund Journal: Diabetes Care Date: 2007-12-10 Impact factor: 19.112
Authors: Lars Bo Andersen; Maarike Harro; Luis B Sardinha; Karsten Froberg; Ulf Ekelund; Søren Brage; Sigmund Alfred Anderssen Journal: Lancet Date: 2006-07-22 Impact factor: 79.321
Authors: Ulf Ekelund; Søren Brage; Karsten Froberg; Maarike Harro; Sigmund A Anderssen; Luis B Sardinha; Chris Riddoch; Lars Bo Andersen Journal: PLoS Med Date: 2006-12 Impact factor: 11.069
Authors: Søren Brage; Ulf Ekelund; Niels Brage; Mark A Hennings; Karsten Froberg; Paul W Franks; Nicholas J Wareham Journal: J Appl Physiol (1985) Date: 2007-04-26
Authors: Eero A Haapala; Petri Wiklund; Niina Lintu; Tuomo Tompuri; Juuso Väistö; Taija Finni; Ina M Tarkka; Titta Kemppainen; Alan R Barker; Ulf Ekelund; Soren Brage; Timo A Lakka Journal: Med Sci Sports Exerc Date: 2020-05
Authors: Eero A Haapala; Henna L Haapala; Heidi Syväoja; Tuija H Tammelin; Taija Finni; Noona Kiuru Journal: J Sport Health Sci Date: 2019-07-12 Impact factor: 7.179
Authors: Aapo Veijalainen; Eero A Haapala; Juuso Väistö; Marja H Leppänen; Niina Lintu; Tuomo Tompuri; Santeri Seppälä; Ulf Ekelund; Mika P Tarvainen; Kate Westgate; Søren Brage; Timo A Lakka Journal: Eur J Appl Physiol Date: 2019-09-18 Impact factor: 3.078
Authors: Lauren Ha; Claire E Wakefield; Joanna Fardell; Richard J Cohn; David Simar; Christina Signorelli; David Mizrahi Journal: Support Care Cancer Date: 2022-08-01 Impact factor: 3.359
Authors: Timo A Lakka; Niina Lintu; Juuso Väistö; Anna Viitasalo; Taisa Sallinen; Eero A Haapala; Tuomo T Tompuri; Sonja Soininen; Panu Karjalainen; Theresia M Schnurr; Santtu Mikkonen; Mustafa Atalay; Tuomas O Kilpeläinen; Tomi Laitinen; David E Laaksonen; Kai Savonen; Soren Brage; Ursula Schwab; Jarmo Jääskeläinen; Virpi Lindi; Aino-Maija Eloranta Journal: Diabetologia Date: 2020-08-20 Impact factor: 10.122
Authors: Ann Pulling Kuhn; Alexandra Cockerham; Nicole O'Reilly; Jacob Bustad; Victor Miranda; Tatiana V Loboda; Maureen M Black; Erin R Hager Journal: Int J Environ Res Public Health Date: 2021-05-09 Impact factor: 3.390